New Study Provides Evidence Supporting the Use of Cannabinoids to Treat Prostate Cancer

Cannabinoids may provide a potential treatment option for prostate cancer, according to a new study published by the journal The Prostate.

“Cannabinoids have demonstrated anticarcinogenic properties in a variety of malignancies, including in prostate cancer”, states researchers. In the present study, they “explored the anti-cancer effects of the synthetic cannabinoid WIN 55,212-2 (WIN) in prostate cancer.”

For the study, “Established prostate cancer cells (PC3, DU145, LNCaP) were treated with varying concentrations of WIN”, and “Cell proliferation was determined by the MTS assay.” The anti-migration and anti-invasive potential of WIN “was examined by the wound healing assay and the matrigel invasion assay.” Cell cycle analysis was performed by flow cytometry, and mechanistic studies were performed by Western blot.

Read moreNew Study Provides Evidence Supporting the Use of Cannabinoids to Treat Prostate Cancer

New Study: Cannabinoids a Promising Tool in Treatment of Breast and Prostate Cancer

Prostate CancerA new study being published in the upcoming issue of the journal Expert Opinion on Investigational Drugs, and published online ahead of print by the U.S. National Institute of Health, has found that cannabinoids may be a promising tool for the treatment of breast and prostate cancer.

According to the study’s abstract; “The aim of this review is to evaluate the promising chemotherapeutic utility of phytocannabinoids, endocannabinoids, and synthetic cannabinoids in breast and prostate cancer.”

In their evaluation, researchers found that; “Cannabinoids, in particular the non-psychoactive CBD, may be promising tools in combination therapy for breast and prostate cancer, due to their direct antitumor effects, their ability to improve the efficacy of conventional antitumor drugs and their usefulness as palliative treatment.”

Read moreNew Study: Cannabinoids a Promising Tool in Treatment of Breast and Prostate Cancer

64 Studies That Show Cannabis Can Treat Various Cancers

Cannabis, and the cannabinoid compounds found within it, has been shown through a large cannabisplantamount of scientific, peer-reviewed research to be effective at treating a wide variety of cancers, ranging from brain cancer to colon cancer. Below is a list of over 60 studies that demonstrate the vast anti-cancer properties of cannabis.

Studies showing cannabis may combat brain cancer:

      • Cannabidiol (CBD) inhibits the proliferation and invasion in U87-MG and T98G glioma cells. Study published in the Public Library of Science journal in October 2013.
      • Tetrahydrocannabinol (THC) can kill cancer cells by causing them to self-digest. Study published in the Journal of Clinical Investigation in September 2013.

      Read more64 Studies That Show Cannabis Can Treat Various Cancers

      Cannabinoids May Treat Prostate Cancer That’s Nonresponsive to Common Therapies

      Cannabinoids may cannabinoidsprovide a treatment option for prostate cancer that has become nonresponsive to common therapy, according to a study published in the February issue of the journal Oncology Reports, and published online this week by the National Institute of Health.

      According to researchers; “In the early stages, prostate cancer is androgen‑ dependent; therefore, medical castration has shown significant results during the initial stages of this pathology. Despite this early effect, advanced prostate cancer is resilient to such treatment.”

      Read moreCannabinoids May Treat Prostate Cancer That’s Nonresponsive to Common Therapies

      Cannabinoids Can Treat, Prevent Prostate Cancer, According to New National Institute of Health Study

      A new study using a compound meant to mimic the medicinal effects of cannabinoids has found that activation of the body’s cannabinoid receptors – something which cannabis does naturallymedical-marijuana-symbol – can prevent, and treat hormone-sensitive prostate cancer. The study was published this month by the U.S. National Institute of Health.

      According to researchers of the study; “In the in vivo treatment, compound 4 [a synthetic cannabinoid] at 2 mg/kg, blocks the growth of LNCaP tumors and reduces the growth of PC-3 tumors generated in mice.”

      Read moreCannabinoids Can Treat, Prevent Prostate Cancer, According to New National Institute of Health Study